A box of Ozempic and contents sit on a table in Dudley, North Tyneside, Britain, on Oct. 31, 2023. Lee Smith/Reuters
The U.S. Food and Drug Administration has warned Novo Nordisk over a consumer ad for its blockbuster diabetes drug, Ozempic, saying the commercial makes false and misleading claims about the drug’s benefits.
We had a problem loading this article. Please enable javascript or use a different browser. If the issue persists, please visit our help center.
Read Full Article: https://www.theepochtimes.com/us/fda-warns-novo-for-second-time-about-misleading-ozempic-advertising-5993761/?utm_source=partner&utm_campaign=whatfinger
